Scolaris Content Display Scolaris Content Display

Diabetes self‐management education and support delivered by mobile health (m‐health) interventions for adults with type 2 diabetes mellitus

This is not the most recent version

References

Additional references

ADA 2003

Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003;26(Suppl 1):S5‐20.

ADA 2008

American Diabetes Association. Standards of medical care in diabetes ‐ 2008. Diabetes Care 2008;31(Suppl 1):S12‐54. [PUBMED: 18165335]

Aitken 2013

Aitken M, Gauntlett C. Patient apps for improved healthcare: from novelty to mainstream. Parsippany (NJ): IMS Institute for Healthcare Informatics; 2013 October.. [ www.imshealth.com/en/thought‐leadership/quintilesims‐institute/reports/patient‐apps‐for‐improved‐healthcare]

Altman 2003

Altman DG, Bland JM. Interaction revisited: the difference between two estimates. BMJ 2003;326(7382):219. [PUBMED: 12543843]

Bell 2013

Bell ML, McKenzie JE. Designing psycho‐oncology randomised trials and cluster randomised trials: variance components and intra‐cluster correlation of commonly used psychosocial measures. Psychooncology 2013;22:1738‐47.

Beller 2013

Beller EM, Chen JK, Wang UL, Glasziou PP. Are systematic reviews up‐to‐date at the time of publication?. Systematic Reviews 2013;2:36.

Borenstein 2017a

Borenstein M, Higgins JP, Hedges LV, Rothstein HR. Basics of meta‐analysis: I² is not an absolute measure of heterogeneity. Research Synthesis Methods 2017;8(1):5‐18.

Borenstein 2017b

Borenstein M. Prediction intervals. www.Meta‐Analysis.com/prediction (accessed 3 July 2017).

Boutron 2014

Boutron I, Altman DG, Hopewell S, Vera‐Badillo F, Tannock I, Ravaud P. Impact of spin in the abstracts of articles reporting results of randomized controlled trials in the field of cancer: the SPIIN randomized controlled trial. Journal of Clinical Oncology 2014;32(36):4120‐6.

Buch 2011

Buch MH, Aletaha D, Emery P, Smolen JS. Reporting of long‐term extension studies: lack of consistency calls for consensus. Annals of the Rheumatic Diseases 2011;70(6):886‐90.

Chomutare 2011

Chomutare T, Fernandez‐Luque L, Arsand E, Hartvigsen G. Features of mobile diabetes applications: review of the literature and analysis of current applications compared against evidence‐based guidelines. Journal of Medical Internet Research 2011;13(3):e65.

CONSORT 2010

Schulz KF, Altman DG, Moher D, the CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. Annals of Internal Medicine2010; Vol. 152, issue 11:726‐32.

Corbett 2014

Corbett MS, Higgins JP, Woolacott NF. Assessing baseline imbalance in randomised trials: implications for the Cochrane risk of bias tool. Research Synthesis Methods 2014;5(1):79‐85.

Cui 2016

Cui M, Wu X, Mao J, Wang X, Nie M. T2DM self‐management via smartphone applications: a systematic review and meta‐analysis. PLOS One 2016;11(11):e0166718.

Deeks 2011

Deeks JJ, Higgins JPT, Altman DG (editors). Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.

Fogg 2009

Fogg BJ. A behaviour model for persuasive design. Proceedings of the 4th International Conference on Persuasive TechnologyApril 2009.

Funnel 2010

Funnell MM, Brown TL, Childs BP, Haas LB, Hosey GM, Jensen B, et al. National standards for diabetes self‐management education. Diabetes Care 2010;33:S89‐96.

GRADEpro GDT 2015 [Computer program]

McMaster University (developed by Evidence Prime). GRADEpro GDT. Version accessed prior to 13 October 2017. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015.

Higgins 2002

Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta‐analysis. Statistics in Medicine 2002;21(11):1539‐58.

Higgins 2003

Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta‐analysis. BMJ 2003;327(7414):557‐60.

Higgins 2011a

Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928.

Higgins 2011b

Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.

Higgins 2011c

Higgins JPT, Deeks JJ, Altman DG (editors). Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.

Hoffmann 2014

Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ 2014;348:g1687.

Hoffmann 2017

Hoffmann TC, Oxman AD, Ioannidis JP, Moher D, Lasserson TJ, Tovey DI, et al. Enhancing the usability of systematic reviews by improving the consideration and description of interventions. BMJ 2017;358:j2998.

Hozo 2005

Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Medical Research Methodology 2005;5:13. [DOI: 10.1186/1471‐2288‐5‐13]

Hróbjartsson 2013

Hróbjartsson A, Thomsen AS, Emanuelsson F, Tendal B, Hilden J, Boutron I, et al. Observer bias in randomized clinical trials with measurement scale outcomes: a systematic review of trials with both blinded and nonblinded assessors. Canadian Medical Association Journal 2013;185(4):E201‐11.

Hunt 2015

Hunt CW. Technology and diabetes self‐management: an integrative review. World Journal of Diabetes 2015;6(2):225‐33.

Janz 1984

Janz NK, Becker MH. The Health Belief Model: a decade later. Health Education 1984;11(1):1‐47.

Jones 2015

Jones CW, Keil LG, Holland WC, Caughey MC, Platts‐Mills TF. Comparison of registered and published outcomes in randomized controlled trials: a systematic review. BMC Medicine 2015;13:282. [DOI: 10.1186/s12916‐015‐0520‐3]

Kirkham 2010

Kirkham JJ, Dwan KM, Altman DG, Gamble C, Dodd S, Smyth R, et al. The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews. BMJ 2010;340:c365. [DOI: 10.1136/bmj.c365]

Leventhal 1998

Leventhal H, Leventhal EA, Contrada EJ. Self‐regulation, health, and behaviour: a perceptual‐cognitive approach. Psychology and Health 1998;13:717‐33.

Liberati 2009

Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic and meta‐analyses of studies that evaluate interventions: explanation and elaboration. PLOS Medicine 2009;6(7):1‐28. [DOI: 10.1371/journal.pmed.1000100]

Lim 2011

Lim S, Kang SM, Shin H, Lee HJ, Won YJ, Yu SH, et al. Improved glycemic control without hypoglycemia in elderly diabetic patients using the Ubiquitous Healthcare Service, a new medical information system. Diabetes Care 2011;34(2):308‐13.

Little 2012

MP Little, P Rajaraman, RE Curtis, SS Devesa, PD Inskip, DP Check, MS Linet. Mobile phone use and glioma risk: comparison of epidemiological study results with incidence trends in the United States. BMJ 2012;344:e1147.

Mathieu 2009

Mathieu S, Boutron I, Moher D, Altman DG, Ravaud P. Comparison of registered and published primary outcomes in randomized controlled trials. JAMA 2009;302:977‐84.

Meader 2014

Meader N, King K, Llewellyn A, Norman G, Brown J, Rodgers M, et al. A checklist designed to aid consistency and reproducibility of GRADE assessments: development and pilot validation. Systematic Reviews 2014;3:82.

Megan 2012

Megan B, Pickering RM, Weatherall M. Design, objectives, execution and reporting of published open‐label extension studies. Journal of Evaluation in Clinical Practice 2012;18(2):209‐15.

Pal 2011

Pal K, Eastwood SV, Michie S, Farmer AJ, Barnard ML, Peacock R, et al. Computer‐based diabetes self‐management interventions for adults with type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2013, Issue 3. [DOI: 10.1002/14651858.CD008776.pub2]

Popp 2015

Popp L, Schneider S. Attention placebo control in randomized controlled trials of psychosocial interventions: theory and practice. Trials 2015;16:150. [DOI: 10.1186/s13063‐015‐0679‐0]

Powers 2015

Powers MA, Bardsley J, Cypress M, Duker P, Funnell MM, Fischl AH, et al. Diabetes self‐management education and support in type 2 diabetes: a joint position statement of the American Diabetes Association, the American Association of Diabetes Educators, and the Academy of Nutrition and Dietetics. Diabetes Care 2015 July;38(7):1372‐82.

Prochaska 2002

Prochaska JO, Redding CA, Evers KE. The transtheoretical model and stages of change. Health Behaviour and Health Education: Theory, Research, and Practice. San Fransisco: Jossy‐Bass, 2002:99‐120.

Quinn 2011

Quinn CC, Shardell MD, Terrin ML, Barr EA, Ballew SH, Gruber‐Baldini AL. Cluster‐randomized trial of a mobile phone personalized behavioral intervention for blood glucose control. Diabetes Care 2011;34(9):1934‐42.

RevMan 2014 [Computer program]

Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.

Riley 2011

Riley RD, Higgins JP, Deeks JJ. Interpretation of random effects meta‐analyses. BMJ 2011;342:d549.

Scherer 2007

Scherer RW, Langenberg P, von EE. Full publication of results initially presented in abstracts. Cochrane Database of Systematic Reviews 2007, Issue 2. [DOI: 10.1002/14651858.MR000005.pub3]

Schünemann 2011

Schünemann HJ, Oxman AD, Higgins JPT, Vist GE, Glasziou P, Guyatt GH, et al. on behalf of the Cochrane Applicability and Recommendations Methods Group and the Cochrane Statistical Methods Group. Chapter 11: Presenting results and ‘Summary of findings' tables. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.

Sharma 2016

Sharma M, Nazareth I, Petersen I. Trends in incidence, prevalence and prescribing in type 2 diabetes mellitus between 2000 and 2013 in primary care: a retrospective cohort study. BMJ Open 2016;6(1):e010210.

Sterne 2011

Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta‐analyses of randomised controlled trials. BMJ 2011;343:d4002.

WHO 1998

Alberti KM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part I: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabetic Medicine 1998;15(7):539‐53.

WHO 2011

mHealth: New horizons for health through mobile technologies. Global Observatory for eHealth series2011; Vol. 3.

Wise 1986

Wise PH, Dowlatshahi DC, Farrant S, Fromson S, Meadows KA. Effect of computer‐based learning on diabetes knowledge and control. Diabetes Care 1986;9(5):504‐8.

Wong 2006

Wong SS, Wilczynski NL, Haynes RB. Comparison of top‐performing search strategies for detecting clinically sound treatment studies and systematic reviews in MEDLINE and EMBASE. Journal of the Medical Library Association 2006;94(4):451‐5.

Wood 2008

Wood L, Egger M, Gluud LL, Schulz KF, Jüni P, Altman DG, et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta‐epidemiological study. BMJ 2008;336(7644):601‐5.

Conceptual framework of how the intervention might workFPG: fasting plasma glucose; HbA1c: glycosylated haemoglobin.
Figures and Tables -
Figure 1

Conceptual framework of how the intervention might work

FPG: fasting plasma glucose; HbA1c: glycosylated haemoglobin.